Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract

Pathogens and Disease

Volumn 72, Issue 1, 2014, Pages 70-73

  Sturdevant, Gail L ^a   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Adaptive immunity; Chlamydiae; Female genital tract; Human and mouse strains; Innate immunity; Rag mice

Indexed keywords

ANIMAL; C57BL MOUSE; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE MODEL; FEMALE; FEMALE GENITAL SYSTEM; GENITAL TRACT INFECTION; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MICROBIOLOGY;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE; GENITALIA, FEMALE; IMMUNITY, INNATE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPRODUCTIVE TRACT INFECTIONS;

EID: 84904754911     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12164     Document Type: Article

References (25)

1. Barron AL, White HJ, Rank RG, Soloff BL & Moses EB (1981) A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J Infect Dis 143: 63-66.
2. Belizario JE (2009) Immunodeficient mouse models: an overview. Open Immunol J 2: 79-85.
3. Brunham RC & Rappuoli R (2013) Chlamydia trachomatis control requires a vaccine. Vaccine 31: 1892-1897.
4. Brunham RC & Rey-Ladino J (2005) Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5: 149-161.
5. CDC Grand Rounds (2011) Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep 60: 370-373.
6. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE & Byrne GI (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 65: 2145-2152.
7. Johansson M, Schön K, Ward M & Lycke N (1997) Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans? Scand J Immunol 46: 546-552.
8. Johnson RE, Newhall WJ, Papp JR et al. (2002) Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections. MMWR Recomm Rep 51: 1-38.
9. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S & Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
10. Morrison RP & Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70: 2741-2751.
11. Nelson DE, Virok DP, Wood H et al. (2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. P Natl Acad Sci USA 102: 10658-10663.
12. Perry LL, Su H, Feilzer K, Messer R, Hughes S, Whitmire W & Caldwell HD (1999) Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol 162: 3541-3548.
13. Ramsey KH, Sigar IM, Schripsema JH, Denman CJ, Bowlin AK, Myers GA & Rank RG (2009) Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect Immun 77: 3284-3293.
14. Rank RG, Soderberg LS & Barron AL (1985) Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun 48: 847-849.
15. Rank RG, Ramsey KH, Pack EA & Williams DM (1992) Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun 60: 4427-4429.
16. Read TD, Myers GS, Brunham RC et al. (2003) Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res 31: 2134-2147.
17. Rekart ML & Brunham RC (2008) Epidemiology of chlamydial infection: are we losing ground? Sex Transm Infect 84: 87-91.
18. Roshick C, Wood H, Caldwell HD & McClarty G (2006) Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun 74: 225-238.
19. Shinkai Y, Rathbun G, Lam KP et al. (1992) RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
20. Sturdevant GL, Kari L, Gardner DJ et al. (2010) Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect Immun 78: 3660-3668.
21. Swenson CE, Donegan E & Schachter J (1983) Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis 148: 1101-1107.
22. Tuffrey M, Falder P & Taylor-Robinson D (1982) Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis. Br J Exp Pathol 63: 539-546.
23. Tuffrey M, Falder P, Gale J & Taylor-Robinson D (1986) Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol 67: 605-616.
24. Williams DM, Byrne GI, Grubbs B, Marshal TJ & Schachter J (1988) Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun 56: 3004-3006.
25. World Health Organization (2001) Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. World Health Organization, Geneva, Switzerland.